The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study - The Lancet Rheumatology
Successful therapeutic rechallenge after a severe episode of high dose methotrexate‑induced choreoathetosis: A case report
Examining the safety of relaxed drug monitoring for methotrexate in response to the COVID-19 pandemic
Continuing laboratory tests for methotrexate therapy | Download Table
Elliot Tapper on X: "Hot take: Methotrexate does not cause liver fibrosis It's ok to be cautious (periodic fibroscan). It's ok to use MTX initiation as a trigger to look for fibrosis
To quantify methotrexate in human plasma by HPLC-MS/MS | DDDT
![PDF] Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/cbaa1feb117d9720c7872debf5f8ac470cd9f5f7/3-Table1-1.png "PDF] Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | Semantic Scholar")
PDF] Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | Semantic Scholar
Methotrexate Testing: An Alternate Diagnostic Option
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ
Summary of recommendations for monitoring hepatotoxicity in patients... | Download Table
Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study - The Lancet Rheumatology
Accurately Measure Methotrexate with AVISE Testing
Therapeutic drug monitoring of methotrexate in disease - Research Outreach
![PDF] Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1e4f0a9a3a90ec9f13d64e26c9737cc6afd59a2f/4-Figure1-1.png "PDF] Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. | Semantic Scholar")
PDF] Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. | Semantic Scholar
Treatment of early rheumatoid arthritis: Methotrexate and beyond - ScienceDirect
Dosing regimen and monitoring guidelines for methotrexate use | Download Table
Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting | HTML | Acta Dermato-Venereologica
Reduced Methotrexate Monitoring Frequency Causes No Adverse Effects - EMJ
Expert Guidelines | Voraxaze
Methotrexate Monitoring in Dermatology— A Retrospective Cohort Study - JDDonline - Journal of Drugs in Dermatology
FIGURE 1. Pharmacokinetically Guided Leucovorin Rescue After HDMTX Administration
Monitoring Methotrexate Use for Inflammatory Arthritis
Leucovorin (folinic acid) rescue for high‐dose methotrexate: A review - Jiang - 2022 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated - ScienceDirect
A single center retrospective analysis of a protocol for high-dose methotrexate and leucovorin rescue administration - Zak Cerminara, Alison Duffy, Jennifer Nishioka, James Trovato, Steven Gilmore, 2019
Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | PLOS ONE
Monitoring Methotrexate Levels in a Patient After Glucarpidase Administration: A Case Report
Methotrexate - A Comprehensive Drug Review in Dermatology | PPT
A Family Physician's Guide to Monitoring Methotrexate | AAFP
Risk stratified monitoring for methotrexate toxicity in immune mediated inflammatory diseases: prognostic model development and validation using primary care data from the UK | The BMJ
Monitoring Methotrexate Therapy | The MRCP Blog
